Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × Thalidomide × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10 Colorectal Neoplasms 6 Colonic Neoplasms 4 Rectal Neoplasms 3 Liver Neoplasms 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Appendiceal Neoplasms 2 Vomiting 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Nausea 1 Multiple Myeloma 1 Meningioma 1

Interventions

Dexamethasone 5 Aprepitant 4 Therapeutics 3 Palonosetron 3 Radiotherapy 2 Ondansetron 2 Gemcitabine 2 Fluorouracil 2 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 casopitant 1 auricularum 1 Yoga 1 Tropisetron 1 Thalidomide 1 Taxes 1 Surveys and Questionnaires 1 Standard of Care 1 Radiation 1 Psychiatric Rehabilitation 1 Oxaliplatin 1 Octreotide 1 Leucovorin 1 L 758298 1 Irinotecan 1 Dronabinol 1 Dosage Forms 1 Docetaxel 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡